Advertisement

Topics

Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics for €210M https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-all-viratherapeutics-shares …

03:11 EDT 13 Sep 2018 | Brad Loncar

Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics for €210M https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-all-viratherapeutics-shares …

Original Article: Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics for €210M https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-all-viratherapeutics-shares …

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics for €210M https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-all-viratherapeutics-shares …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...